TRANSPLANT PROCEDURES. Any costs related to transplant procedures, including but not limited to the transplant of human, artificial, or animal organs, cells or tissue.
TRANSPLANT PROCEDURES. The maximum amount payable for the transplan- tation of human organs, cells, and tissue benefit is six hundred thousand dollars (US$600,000) per insured, per diagnosis, per lifetime after the applicable deduct- ible. This transplant benefit begins once the need for transplantation has been determined by a physician, has been certified by a second surgical or medical opinion, and has been approved by USA Medical Services, and is subject to all the terms, provisions, and exclusions of the policy. This benefit includes:
(a) Pre-transplant care, including those services directly related to evaluation of the need for transplantation, evaluation of the insured for the transplant procedure, and preparation and stabilization of the insured for the transplant procedure.
(b) Pre-surgical workup, including all laboratory and X-ray exams, CT scans, Magnetic Resonance Imaging (MRI’s), ultrasounds, biopsies, scans, medications and supplies.
(c) The costs of organ, cell or tissue procurement, transportation, and harvesting including bone marrow, stem cell or cord blood storage or banking are covered up to a maximum of twenty-five thousand dollars (US$25,000) per diagnosis, which is included as part of the maximum transplant benefit. The donor workup, including testing of potential donors for a match is included in this benefit.
(d) The hospitalization, surgeries, physician and surgeon’s fees, anesthesia, medi- cation, and any other treatment necessary during the transplant procedure.
(e) Post-transplant care including, but not limited to any medically necessary follow-up treatment resulting from the transplant and any complications that arise after the transplant procedure, whether a direct or indirect consequence of the transplant.
(f) Medication or therapeutic measures used to ensure the viability and perma- nence of the transplanted organ, cell or tissue.
(g) Home health care, nursing care (e.g. wound care, infusion, assessment, etc.), emergency transportation, medical attention, clinic or office visits, transfusions, supplies, or medication related to the transplant.
TRANSPLANT PROCEDURES. The maxi- mum amount payable for the transplanta- tion of human organs, cells, and tissue ben- efit is seven hundred fifty thousand dollars (US$750,000) per insured, per diagnosis, per lifetime after the applicable deductible. This transplant benefit begins once the need for transplantation has been deter- mined by a physician, has been certified by a second surgical or medical opinion, and has been approved by USA Medical Services, and is subject to all the terms, provisions, and exclusions of the policy. POLICY CONDITIONS | 9 This benefit includes:
(a) Pre-transplant care, including those services directly related to evaluation of the need for transplantation, eval- uation of the insured for the trans- plant procedure, and preparation and stabilization of the insured for the transplant procedure.
(b) Pre-surgical workup, including all laboratory and X-ray exams, CT scans, Magnetic Resonance Imaging (MRI’s), ultrasounds, biopsies, scans, medica- tions and supplies.
(c) The costs of organ, cell or tissue procurement, transportation, and harvesting including bone marrow, stem cell or cord blood storage or banking are covered up to a maximum of twenty-five thousand dollars (US$25,000) per diagnosis, which is included as part of the maximum transplant benefit. The donor workup, including testing of potential donors for a match is included in this benefit.
(d) The hospitalization, surgeries, physi- cian and surgeon’s fees, anesthesia, medication, and any other treatment necessary during the transplant procedure.
(e) Post-transplant care including, but not limited to any medically neces- sary follow-up treatment resulting from the transplant and any compli- cations that arise after the transplant procedure, whether a direct or indi- rect consequence of the transplant.
(f) Medication or therapeutic measures used to ensure the viability and permanence of the transplanted organ, cell or tissue.
(g) Home health care, nursing care (e.g. wound care, infusion, assessment, etc.), emergency transportation, medical attention, clinic or office visits, transfusions, supplies, or medi- cation related to the transplant.
TRANSPLANT PROCEDURES. Coverage for transplantation of human organs, cells and tissues is provided only within the insurer’s Provider Network for Transplant Pro- cedures. There is no coverage outside the Provider Network for Transplant Procedures. The maximum amount payable for this benefit is one million dollars (US$1,000,000) per insured, per diagnosis, per lifetime, after the applicable deductible. Bone marrow transplants derived from a cancer diagnosis will be covered under the cancer benefit, as indicated in the Table of Benefits. This transplant benefit begins once the need for transplantation has been determined by a physician, has been certified by a second surgical or medical opinion, and has been approved by USA Medical Services, and is subject to all the terms, conditions and exclusions of the policy.
(a) Pre-transplant care, including those services directly related to evaluation of the need for transplantation, evaluation of the insured for the transplant procedure, and preparation and stabilization of the insured for the transplant procedure.
(b) Pre-surgical workup, including all laboratory and X-ray exams, CT scans, Magnetic Resonance Imaging (MRI’s), ultrasounds, biopsies, scans, medications and supplies.
(c) The costs of organ, cell or tissue procurement, transportation, and harvesting including bone marrow and stem cell storage or banking are covered up to a maximum of forty thousand dollars (US$40,000) per diagnosis, which is included as part of the maximum transplant benefit. The donor workup, including testing of potential donors for a match is included in this benefit.
(d) The hospitalization, surgeries, physician and surgeon’s fees, anesthesia, medication, and any other treatment necessary during the transplant procedure.
(e) Post-transplant care including, but not limited to any medically necessary follow-up treatment resulting from the transplant and any complications that arise after the transplant procedure, whether a direct or indirect consequence of the transplant.
(f) Medication or therapeutic measures used to ensure the viability and permanence of the transplanted organ, cell or tissue.
(g) Home health care, nursing care (e.g. wound care, infusion, assessment, etc.), emergency transportation, medical attention, clinic or office visits, transfusions, supplies, or medication related to the transplant. There is an optional rider available for additional transplant coverage.
TRANSPLANT PROCEDURES. The maximum amount payable for the transplanta- tion of human organs, cells, and tissue benefit is one million five hundred thousand dollars (US$1,500,000) per insured, per diagnosis, per lifetime after the applicable deductible. Bone marrow transplants derived from a cancer diagnosis will be covered
(a) Pre-transplant care, including those services directly related to evaluation of the need for transplantation, evaluation of the insured for the transplant procedure, and preparation and stabilization of the insured for the transplant procedure.
(b) Pre-surgical workup, including all laboratory and X-ray exams, CT scans, Magnetic Resonance Imaging (MRI’s), ultrasounds, biopsies, scans, medications and supplies.
(c) The costs of organ, cell or tissue procurement, transportation, and harvesting including bone marrow and stem cell storage or banking are covered up to a maximum of fifty thousand dollars (US$50,000) per diagnosis, which is included as part of the maximum transplant benefit. The donor workup, including testing of potential donors for a match is included in this benefit.
(d) The hospitalization, surgeries, physician and surgeon’s fees, anesthesia, medication, and any other treatment necessary during the transplant procedure.
(e) Post-transplant care including, but not limited to any medically necessary follow-up treatment resulting from the transplant and any complications that arise after the transplant procedure, whether a direct or indirect consequence of the transplant.
(f) Medication or therapeutic measures used to ensure the viability and permanence of the transplanted organ, cell or tissue.
(g) Home health care, nursing care (e.g. wound care, infusion, assessment, etc.), emergency transportation, medical attention, clinic or office visits, transfusions, supplies, or medication related to the transplant.
